Inpharma Weekly


ISSN: 1173-8324        年代:2004
当前卷期:Volume &NA;  issue 1439     [ 查看所有卷期 ]

年代:2004
 
     Volume &NA;  issue 1419   
     Volume &NA;  issue 1420   
     Volume &NA;  issue 1421   
     Volume &NA;  issue 1422   
     Volume &NA;  issue 1423   
     Volume &NA;  issue 1424   
     Volume &NA;  issue 1425   
     Volume &NA;  issue 1426   
     Volume &NA;  issue 1427   
     Volume &NA;  issue 1428   
     Volume &NA;  issue 1429   
     Volume &NA;  issue 1430   
     Volume &NA;  issue 1431   
     Volume &NA;  issue 1432-1433   
     Volume &NA;  issue 1434   
     Volume &NA;  issue 1435   
     Volume &NA;  issue 1436   
     Volume &NA;  issue 1437   
     Volume &NA;  issue 1438   
     Volume &NA;  issue 1439
     Volume &NA;  issue 1440   
     Volume &NA;  issue 1441   
     Volume &NA;  issue 1442   
     Volume &NA;  issue 1443   
     Volume &NA;  issue 1444   
     Volume &NA;  issue 1445   
     Volume &NA;  issue 1446   
     Volume &NA;  issue 1447   
     Volume &NA;  issue 1448   
     Volume &NA;  issue 1449   
     Volume &NA;  issue 1450   
     Volume &NA;  issue 1451   
     Volume &NA;  issue 1452   
     Volume &NA;  issue 1453   
     Volume &NA;  issue 1454   
     Volume &NA;  issue 1455   
     Volume &NA;  issue 1456   
     Volume &NA;  issue 1457   
     Volume &NA;  issue 1458   
     Volume &NA;  issue 1459   
     Volume &NA;  issue 1460   
     Volume &NA;  issue 1461   
     Volume &NA;  issue 1462   
     Volume &NA;  issue 1463   
     Volume &NA;  issue 1464   
     Volume &NA;  issue 1465   
     Volume &NA;  issue 1466   
     Volume &NA;  issue 1467   
     Volume &NA;  issue 1468   
1. Off-label gabapentin sales are still soaring despite evidence of its ineffectiveness in some indications,
  Inpharma Weekly,   Volume  &NA;,   Issue  1439,   2004,   Page  2-2

&NA;,  

Preview

2. "The relationship between adherence and resistance to HIV antiretroviral therapy is more complex than 'non-adherence increases the risk of drug resistance'",
  Inpharma Weekly,   Volume  &NA;,   Issue  1439,   2004,   Page  3-3

&NA;,  

Preview

3. Antioxidant vitamins: why trials conflict with observational studies
  Inpharma Weekly,   Volume  &NA;,   Issue  1439,   2004,   Page  4-4

&NA;,  

Preview

4. Newer, second-generation antipsychotics are prescribed for off-label indications far more often than first-generation antipsychotics in ordinary inpatient practice in Italy,
  Inpharma Weekly,   Volume  &NA;,   Issue  1439,   2004,   Page  5-5

&NA;,  

Preview

5. Alagebrium chloride*may be effective in difficult-to-treat systolic hypertension,
  Inpharma Weekly,   Volume  &NA;,   Issue  1439,   2004,   Page  7-7

&NA;,  

Preview

6. The injectable protein LEA 29Y*may be a favourable treatment option for kidney transplant recipients,
  Inpharma Weekly,   Volume  &NA;,   Issue  1439,   2004,   Page  8-8

&NA;,  

Preview

7. Intranasal zolmitriptan: rapid, reliable relief for migraine symptoms
  Inpharma Weekly,   Volume  &NA;,   Issue  1439,   2004,   Page  9-10

R Roper,,  

Preview

8. Zinc acetate accelerates recovery in infants with severe pneumonia,
  Inpharma Weekly,   Volume  &NA;,   Issue  1439,   2004,   Page  10-10

&NA;,  

Preview

9. Inhaled beclomethasone equivalent to oral theophylline in pregnancy
  Inpharma Weekly,   Volume  &NA;,   Issue  1439,   2004,   Page  11-11

&NA;,  

Preview

10. Ketamine provides substantial pain relief to patients with neuropathic pain after spinal cord injury
  Inpharma Weekly,   Volume  &NA;,   Issue  1439,   2004,   Page  12-12

&NA;,  

Preview

首页 上一页 下一页 尾页 第1页 共21条